Migraine

Migraine is a neurological condition characterized by recurrent, often severe headache episodes that can be accompanied by sensitivity to light or sound, nausea, and visual disturbances known as aura. The Migraine category on an online pharmacy groups medicines used to relieve acute migraine attacks and medicines intended to reduce how often attacks occur. The range covers simple over‑the‑counter pain relievers as well as prescription treatments developed specifically for migraine, reflecting the varied ways people manage the condition depending on frequency, intensity and accompanying symptoms.

Many users turn to acute treatments at the first sign of a migraine to shorten attack duration and reduce pain and associated symptoms such as nausea and vomiting. Preventive or prophylactic therapies are selected when attacks are frequent, disabling or do not respond well to acute options; these are taken on a regular schedule to lower attack frequency and severity over time. Some medications are used as adjuncts to control particular features—antiemetics to relieve nausea, for example—while others are reserved for more severe or treatment‑resistant patterns of migraine.

The category contains several broad classes of medicines. Over‑the‑counter analgesics such as ibuprofen, naproxen and paracetamol (acetaminophen) are commonly used for milder attacks or in combination with other agents. Triptans are a class of migraine‑specific acute treatments; examples include sumatriptan, rizatriptan, zolmitriptan and eletriptan, available in oral tablets, nasal sprays or injectable forms. Ergot derivatives such as dihydroergotamine and certain combination analgesics with caffeine are also represented. For prevention, oral medications frequently used include beta‑blockers (for example propranolol), anticonvulsants (such as topiramate or valproate), and some tricyclic antidepressants like amitriptyline. Newer preventive options targeting the calcitonin gene‑related peptide (CGRP) pathway include monoclonal antibodies such as erenumab, fremanezumab, galcanezumab and eptinezumab, which are provided as periodic injections. Antiemetic agents such as metoclopramide or domperidone may be offered to address nausea that can accompany migraine attacks.

How these medicines are used varies by formulation and purpose. Acute medications are generally taken at the onset of symptoms, with some formulations designed for rapid absorption or alternative routes when nausea limits oral intake; nasal sprays and subcutaneous injections provide faster onset for some triptans and other agents. Preventive therapies are characteristically administered on a regular schedule and may require several weeks to show benefit, while injectable preventive biologics are typically given monthly or quarterly. Combination strategies—using an acute agent alongside a preventer—are common for people with more frequent or severe migraines.

Safety profiles and suitability differ markedly across the medicines in this category. Some migraine medicines can cause side effects such as drowsiness, dizziness, gastrointestinal upset, or changes in weight or mood. Specific groups of drugs have important contraindications or cautions; for example, certain acute medications are not appropriate for people with particular cardiovascular conditions, and some preventives are avoided in pregnancy. Drug interactions are possible with several agents, and considerations such as existing medical conditions, concurrent medications and route of administration affect tolerability. Product information and regulatory labeling typically describe these issues in detail.

When selecting a medicine for migraine, people commonly compare factors such as whether the product is for acute relief or prevention, expected speed of onset, duration of effect, route of administration (tablet, dissolvable tablet, nasal spray, injection), and the likelihood of side effects. Availability (over‑the‑counter versus prescription), prior response to similar treatments, and convenience of dosing also influence choices. Product pages and informational materials often summarize indications, typical uses and formulation options to help users identify relevant treatments, while regulatory status and official prescribing information provide further detail about each medicine.